Press Releases

Press Releases

May 15, 2023
Preclinical data highlights AH-001 as potentially compelling targeted dermatology treatment options.
April 25, 2023
Company’s proprietary drug discovery platform provides unique approach to rationally design bi-functional degraders and molecular glues to have differentiated drug profiles.
July 15, 2022
After 6 months of close collaboration with our AI and drug design teams in discovery, we have advanced the drug profile...
Scroll to Top